Details for New Drug Application (NDA): 019829

✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions

NDA 019829 describes CERETEC, which is a drug marketed by Ge Healthcare and is included in one NDA. It is available from three suppliers. Additional details are available on the CERETEC profile page.

The generic ingredient in CERETEC is technetium tc-99m exametazime kit. There are four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the technetium tc-99m exametazime kit profile page.

Summary for 019829

Tradename:	CERETEC
Applicant:	Ge Healthcare
Ingredient:	technetium tc-99m exametazime kit
Patents:	0

Pharmacology for NDA: 019829

Mechanism of Action	Radiopharmaceutical Activity

Suppliers and Packaging for NDA: 019829

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CERETEC	technetium tc-99m exametazime kit	INJECTABLE;INJECTION	019829	NDA	Medi-Physics Inc. dba GE Healthcare.	17156-022	17156-022-05	5 VIAL in 1 TRAY (17156-022-05) / 5 mL in 1 VIAL
CERETEC	technetium tc-99m exametazime kit	INJECTABLE;INJECTION	019829	NDA	Medi-Physics Inc.	17156-023	17156-023-05	1 KIT in 1 CARTON (17156-023-05) * 5 VIAL in 1 TRAY / 4.5 mL in 1 VIAL * 5 VIAL in 1 TRAY / 1 mL in 1 VIAL * 5 VIAL in 1 TRAY (17156-022-05) / 5 mL in 1 VIAL

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	INJECTABLE;INJECTION			Strength	N/A
Approval Date:	Dec 30, 1988	TE:		RLD:	Yes

Expired US Patents for NDA 019829

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ge Healthcare	CERETEC	technetium tc-99m exametazime kit	INJECTABLE;INJECTION	019829-001	Dec 30, 1988	⤷ Try a Trial	⤷ Try a Trial
Ge Healthcare	CERETEC	technetium tc-99m exametazime kit	INJECTABLE;INJECTION	019829-001	Dec 30, 1988	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.